TrialThe oncologist2025

Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study.

Andrew J Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.